Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):企業の財務・戦略的SWOT分析

◆英語タイトル:Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH139222FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) carries out the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw materials and preparations, bio-engineering drugs, and nutritious and health products. Its product portfolio includes suxiao jiuxin wan, ticlopidine hydrochloride tablets, cold soft capsules, verapamil hydrochloride tablets, anti-bone hyperplasia pill, pregnant women jinhua tablets, and diarrhea and sputum tablets, and others. TZPG also conducts research and development to develop new pharmaceutical products. The company’s products are used to treat cardiovascular disease, cold, vomit, diarrhea, dyspepsia, chemotherapy, diabetes, skin diseases, gastrointestinal and pneumonia. TZPG is headquartered in Tianjin, China.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Key Recent Developments

Apr 01,2021: Zhongxin Pharm won the award of “2019 Top 100 Chinese National Medicine Brand Enterprises”
Mar 28,2021: Announcement of Zhongxin Pharmaceutical on the tender offer of Jinhushen Biomedical Technology Co., Ltd. to acquire company shares

This comprehensive SWOT profile of Tianjin Zhongxin Pharmaceutical Group Corp Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Tianjin Zhongxin Pharmaceutical Group Corp Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Information
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Overview
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Employees
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Employee Biographies
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Operational Heads
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Major Products and Services
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – History
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Company Statement
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Locations And Subsidiaries
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Business Description
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Corporate Strategy
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – SWOT Analysis
SWOT Analysis – Overview
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Strengths
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Weaknesses
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Opportunities
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Threats
Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Tianjin Zhongxin Pharmaceutical Group Corp Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Information
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Ratios
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Share Data
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Major Products and Services
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, History
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Employees
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Employee Biographies
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Operational Heads
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Other Locations
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Subsidiaries
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Key Competitors
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, SWOT Analysis
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Ratios based on current share price
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Annual Ratios
Tianjin Zhongxin Pharmaceutical Group Corp Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EVN AG (EVN)-エネルギー分野:企業M&A・提携分析
    Summary EVN AG (EVN) is an energy and environmental services company. It provides electricity, natural gas, heat, drinking water, wastewater treatment, thermal waste utilization, and related services. The company produces power from thermal and renewable sources. EVN procures electricity, natural ga …
  • Hydro-Quebec:電力:M&Aディール及び事業提携情報
    Summary Hydro-Quebec is a government-owned energy utility that generates, transmits and distributes electricity. The company specializes in renewable energy generation, using hydro sources and supports the development of electricity using other technologies such as wind energy and biomass. It genera …
  • Twist Bioscience Corp:医療機器:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a DNA specializing and development company that develops DNA products ad DNA synthesis process. The company provides products includes DNA pools for gRNA cloning such as unamplified oligo pools, cloning-ready oligo pools; protein scanning single va …
  • Genomic Health Inc (GHDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Hyundai Engineering & Construction Co Ltd (000720):電力:M&Aディール及び事業提携情報
    Summary Hyundai Engineering & Construction Co Ltd (Hyundai E&C), a subsidiary of Hyundai Motor Co, is an engineering and construction contracting company. It provides civil and construction works for roads, bridges, harbors, highways and railways. It also undertakes property development of residenti …
  • Equinix Inc (EQIX):企業の財務・戦略的SWOT分析
    Equinix Inc (EQIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bounty Oil & Gas NL (BUY):企業の財務・戦略的SWOT分析
    Bounty Oil & Gas NL (BUY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Andeavor Corporation:企業の戦略・SWOT・財務情報
    Andeavor Corporation - Strategy, SWOT and Corporate Finance Report Summary Andeavor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • EQUATE Petrochemical Co:企業の戦略的SWOT分析
    EQUATE Petrochemical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Georgia Power Co:企業の発電所・SWOT分析2018
    Georgia Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Partner Reinsurance Asia Pte. Ltd.
    Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Investment Technology Group, Inc.
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Abu Dhabi National Energy Co (TAQA):企業の財務・戦略的SWOT分析
    Abu Dhabi National Energy Co (TAQA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nordea Bank AB:企業のM&A・事業提携・投資動向
    Nordea Bank AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nordea Bank AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Laboratoires Thea SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoires Thea SA (Thea) is an independent pharmaceutical company that researches, develops, manufactures, and commercializes a range of eye care products. The company’s products find application in the diagnosis, surgery and treatment of ophthalmic diseases such as dry eye, allergies, gl …
  • Shire Plc (SHP):製薬・医療:M&Aディール及び事業提携情報
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to treat patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • iVascular SLU:製品パイプライン分析
    Summary iVascular SLU (iVascular) designs, develops and manufactures advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. It offers portfolio of products in the fields of interventional cardiology, endovascular intervention and interventional neuroradio …
  • Entegris Inc (ENTG):企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Pentair plc:企業の戦略・SWOT・財務分析
    Pentair plc - Strategy, SWOT and Corporate Finance Report Summary Pentair plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • T-Mobile Netherlands Holding B.V.:企業の戦略的SWOT分析
    T-Mobile Netherlands Holding B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆